These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7459947)

  • 21. [Hodgkin disease treated at the Tromsø regional hospital 1985-93. Diagnosis, treatment, prognosis, quality of life and costs of a decentralized treatment].
    Norum J; Wist E
    Tidsskr Nor Laegeforen; 1997 Jan; 117(1):23-6. PubMed ID: 9064805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical features and combined treatment of the central nervous system in Hodgkin's disease].
    Filatova LV; Gershanovich ML
    Vopr Onkol; 2008; 54(5):643-52. PubMed ID: 19069483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapy.
    Czyz J; Szydlo R; Knopinska-Posluszny W; Hellmann A; Gozdzik J; Hansz J; Smolewski P; Robak T; Osowiecki M; Walewski J; Avigdor A; Nagler A; Zemelka T; Pawlicki M; Sawicki Z; Wojtukiewicz M; Kachel L; Holowiecki J; Charlinski G; Jedrzejczak WW
    Bone Marrow Transplant; 2004 Jun; 33(12):1225-9. PubMed ID: 15094747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Primarily detected lymphogranulomatosis].
    Ardashev VN; Kizhaev EV; Zav'ialov MS
    Voen Med Zh; 2000 Feb; 321(2):41-8. PubMed ID: 10870447
    [No Abstract]   [Full Text] [Related]  

  • 25. Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor.
    Weihrauch MR; Manzke O; Beyer M; Haverkamp H; Diehl V; Bohlen H; Wolf J; Schultze JL
    Cancer Res; 2005 Jul; 65(13):5516-9. PubMed ID: 15994922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Simultaneous occurrence of breast carcinoma and malignant lymphoma. Case observations and literature review].
    Frey BM; Morant R; Senn HJ; Fisch T; Schmid U
    Schweiz Med Wochenschr; 1994 Jun; 124(23):1010-6. PubMed ID: 8023099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ichthyosis acquisita and malignant lymphogranuloma (author's transl)].
    Kubec K
    Cesk Dermatol; 1979 Feb; 54(1):3-5. PubMed ID: 761237
    [No Abstract]   [Full Text] [Related]  

  • 28. High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research Group.
    Czyz J; Hellmann A; Dziadziuszko R; Hansz J; Goździk J; Hołowiecki J; Stella-Hołowiecka B; Kachel Ł; Knopińska-Posłuszny W; Nagler A; Meder J; Walewski J; Lampka E; Sułek K; Sawicki W; Lange A; Forgacz K; Suchnicki K; Pacuszko T; Skotnicki A; Mensah P; Jurczak W; Kuliczkowski K; Wróbel T; Mazur G; Dmoszyńska A; Wach M; Robak T; Warzocha K
    Bone Marrow Transplant; 2002 Jul; 30(1):29-34. PubMed ID: 12105774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of the prognostic score for advanced Hodgkin's disease in patients with human immunodeficiency virus-associated Hodgkin's lymphoma.
    Ribera JM; Navarro JT; Oriol A; Vaquero M; Grau J; Feliu E
    Haematologica; 2000 Mar; 85(3):325-6. PubMed ID: 10702829
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hodgkin disease. Diagnosis, clinical course, prognosis, treatment].
    Leporrier M
    Rev Prat; 1995 Sep; 45(13):1669-74. PubMed ID: 7569695
    [No Abstract]   [Full Text] [Related]  

  • 31. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
    Urquhart A; Berg R
    Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evolution of diagnostic and therapeutic methods in childhood Hodgkin's disease].
    Kolygin BA; Safonova SA; Malinin AP; Vesnin AG; Borodina AF; Punanov IuA
    Vopr Onkol; 1997; 43(4):389-92. PubMed ID: 9381685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).
    Lazarus HM; Loberiza FR; Zhang MJ; Armitage JO; Ballen KK; Bashey A; Bolwell BJ; Burns LJ; Freytes CO; Gale RP; Gibson J; Herzig RH; LeMaistre CF; Marks D; Mason J; Miller AM; Milone GA; Pavlovsky S; Reece DE; Rizzo JD; van Besien K; Vose JM; Horowitz MM
    Bone Marrow Transplant; 2001 Feb; 27(4):387-96. PubMed ID: 11313668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The prognosis of Hodgkin disease].
    Kuse R; Calavrezos A; Hausmann K
    Lebensversicher Med; 1982 Sep; 34(7):157-60. PubMed ID: 6127580
    [No Abstract]   [Full Text] [Related]  

  • 35. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma.
    Klumpp TR; Mangan KF; Glenn LD; Malaspina DR; Cropper T; Mullaney M; Macdonald JS
    Bone Marrow Transplant; 1993 Oct; 12(4):337-45. PubMed ID: 7506091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Contribution to the study of the osseous localiza tions of malignant lymphogranuloma].
    Franco L; Anfossi F; Rossi PL
    Minerva Radiol; 1966 Nov; 11(11):551-8. PubMed ID: 5996290
    [No Abstract]   [Full Text] [Related]  

  • 37. Primary mediastinal malignancies: findings in 219 patients.
    Temes R; Chavez T; Mapel D; Ketai L; Crowell R; Key C; Follis F; Pett S; Wernly J
    West J Med; 1999 Mar; 170(3):161-6. PubMed ID: 10214103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of hematotoxicity and sex in patients with Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group.
    Klimm B; Reineke T; Haverkamp H; Behringer K; Eich HT; Josting A; Pfistner B; Diehl V; Engert A;
    J Clin Oncol; 2005 Nov; 23(31):8003-11. PubMed ID: 16204002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does chemosensitivity-assay-directed therapy have an influence on the prognosis of patients with malignant melanoma stage IV? A retrospective study of 14 patients with malignant melanoma stage IV.
    Doerler M; Hyun J; Venten I; Potthoff A; Bartke U; Serova K; Hoextermann S; Altmeyer P; Brockmeyer NH
    Eur J Med Res; 2007 Oct; 12(10):497-502. PubMed ID: 18024256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials.
    Shimabukuro-Vornhagen A; Haverkamp H; Engert A; Balleisen L; Majunke P; Heil G; Eich HT; Stein H; Diehl V; Josting A
    J Clin Oncol; 2005 Aug; 23(24):5739-45. PubMed ID: 16009944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.